Hycor Blood Screening Allowed to Be Marketed
- Share via
Dow Jones
Hycor Biomedical Inc. said Thursday that it has received approval from the Food and Drug Administration to sell a new autoimmune screening test in the United States.
The Garden Grove maker of diagnostic products said in a press release that its newly approved Anti-Cardiolipin Screen ELISA works with two previously approved autoimmune kits.
The kits detect antibodies associated with antiphospholipid syndrome, which can lead to blood clots, strokes or heart attacks.
Inside the business of entertainment
The Wide Shot brings you news, analysis and insights on everything from streaming wars to production — and what it all means for the future.
You may occasionally receive promotional content from the Los Angeles Times.
